These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16392789)

  • 1. Imidazo[1,2-a]pyrimidines as functionally selective and orally bioavailable GABA(A)alpha2/alpha3 binding site agonists for the treatment of anxiety disorders.
    Goodacre SC; Street LJ; Hallett DJ; Crawforth JM; Kelly S; Owens AP; Blackaby WP; Lewis RT; Stanley J; Smith AJ; Ferris P; Sohal B; Cook SM; Pike A; Brown N; Wafford KA; Marshall G; Castro JL; Atack JR
    J Med Chem; 2006 Jan; 49(1):35-8. PubMed ID: 16392789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazo[1,2-a]pyrazin-8-ones, imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,1-f][1,2,4]triazin-8-ones as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
    Goodacre SC; Hallett DJ; Carling RW; Castro JL; Reynolds DS; Pike A; Wafford KA; Newman R; Atack JR; Street LJ
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1582-5. PubMed ID: 16384707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazo[1,2-b][1,2,4]triazines as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
    Jennings AS; Lewis RT; Russell MG; Hallett DJ; Street LJ; Castro JL; Atack JR; Cook SM; Lincoln R; Stanley J; Smith AJ; Reynolds DS; Sohal B; Pike A; Marshall GR; Wafford KA; Sheppard WF; Tye SJ
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1477-80. PubMed ID: 16386900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of imidazo[1,2-b][1,2,4]triazines as GABA(A) alpha2/3 subtype selective agonists for the treatment of anxiety.
    Russell MG; Carling RW; Street LJ; Hallett DJ; Goodacre S; Mezzogori E; Reader M; Cook SM; Bromidge FA; Newman R; Smith AJ; Wafford KA; Marshall GR; Reynolds DS; Dias R; Ferris P; Stanley J; Lincoln R; Tye SJ; Sheppard WF; Sohal B; Pike A; Dominguez M; Atack JR; Castro JL
    J Med Chem; 2006 Feb; 49(4):1235-8. PubMed ID: 16480260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
    Lewis RT; Blackaby WP; Blackburn T; Jennings AS; Pike A; Wilson RA; Hallett DJ; Cook SM; Ferris P; Marshall GR; Reynolds DS; Sheppard WF; Smith AJ; Sohal B; Stanley J; Tye SJ; Wafford KA; Atack JR
    J Med Chem; 2006 Apr; 49(8):2600-10. PubMed ID: 16610803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding site.
    Street LJ; Sternfeld F; Jelley RA; Reeve AJ; Carling RW; Moore KW; McKernan RM; Sohal B; Cook S; Pike A; Dawson GR; Bromidge FA; Wafford KA; Seabrook GR; Thompson SA; Marshall G; Pillai GV; Castro JL; Atack JR; MacLeod AM
    J Med Chem; 2004 Jul; 47(14):3642-57. PubMed ID: 15214791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal models.
    Carling RW; Madin A; Guiblin A; Russell MG; Moore KW; Mitchinson A; Sohal B; Pike A; Cook SM; Ragan IC; McKernan RM; Quirk K; Ferris P; Marshall G; Thompson SA; Wafford KA; Dawson GR; Atack JR; Harrison T; Castro JL; Street LJ
    J Med Chem; 2005 Nov; 48(23):7089-92. PubMed ID: 16279764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
    Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM
    J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperazine imidazo[1,5-a]quinoxaline ureas as high-affinity GABAA ligands of dual functionality.
    Jacobsen EJ; Stelzer LS; TenBrink RE; Belonga KL; Carter DB; Im HK; Im WB; Sethy VH; Tang AH; VonVoigtlander PF; Petke JD; Zhong WZ; Mickelson JW
    J Med Chem; 1999 Apr; 42(7):1123-44. PubMed ID: 10197957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA A receptor subtype selectivity underlying selective anxiolytic effect of baicalin.
    Wang F; Xu Z; Ren L; Tsang SY; Xue H
    Neuropharmacology; 2008 Dec; 55(7):1231-7. PubMed ID: 18723037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1.
    Carling RW; Moore KW; Street LJ; Wild D; Isted C; Leeson PD; Thomas S; O'Connor D; McKernan RM; Quirk K; Cook SM; Atack JR; Wafford KA; Thompson SA; Dawson GR; Ferris P; Castro JL
    J Med Chem; 2004 Mar; 47(7):1807-22. PubMed ID: 15027873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-quinolone derivatives: high-affinity ligands at the benzodiazepine site of brain GABA A receptors. synthesis, pharmacology, and pharmacophore modeling.
    Lager E; Andersson P; Nilsson J; Pettersson I; Nielsen EØ; Nielsen M; Sterner O; Liljefors T
    J Med Chem; 2006 Apr; 49(8):2526-33. PubMed ID: 16610795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazo[1,2-a]pyrimidines as functionally selective GABA(A) ligands.
    Blackaby WP; Atack JR; Bromidge F; Castro JL; Goodacre SC; Hallett DJ; Lewis RT; Marshall GR; Pike A; Smith AJ; Street LJ; Tattersall DF; Wafford KA
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1175-9. PubMed ID: 16406613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunit.
    Russell MG; Carling RW; Atack JR; Bromidge FA; Cook SM; Hunt P; Isted C; Lucas M; McKernan RM; Mitchinson A; Moore KW; Narquizian R; Macaulay AJ; Thomas D; Thompson SA; Wafford KA; Castro JL
    J Med Chem; 2005 Mar; 48(5):1367-83. PubMed ID: 15743180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors.
    Atwal KS; O'Neil SV; Ahmad S; Doweyko L; Kirby M; Dorso CR; Chandrasena G; Chen BC; Zhao R; Zahler R
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4796-9. PubMed ID: 16870436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists.
    Baxter A; Cooper A; Kinchin E; Moakes K; Unitt J; Wallace A
    Bioorg Med Chem Lett; 2006 Feb; 16(4):960-3. PubMed ID: 16297626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: functionally selective GABAA alpha3-subtype agonists.
    Carling RW; Russell MG; Moore KW; Mitchinson A; Guiblin A; Smith A; Wafford KA; Marshall G; Atack JR; Street LJ
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3550-4. PubMed ID: 16621541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonist.
    Liverton NJ; Bednar RA; Bednar B; Butcher JW; Claiborne CF; Claremon DA; Cunningham M; DiLella AG; Gaul SL; Libby BE; Lyle EA; Lynch JJ; McCauley JA; Mosser SD; Nguyen KT; Stump GL; Sun H; Wang H; Yergey J; Koblan KS
    J Med Chem; 2007 Feb; 50(4):807-19. PubMed ID: 17249648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans.
    Atack JR; Wafford KA; Street LJ; Dawson GR; Tye S; Van Laere K; Bormans G; Sanabria-Bohórquez SM; De Lepeleire I; de Hoon JN; Van Hecken A; Burns HD; McKernan RM; Murphy MG; Hargreaves RJ
    J Psychopharmacol; 2011 Mar; 25(3):314-28. PubMed ID: 20147571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics.
    Atack JR
    Expert Opin Investig Drugs; 2005 May; 14(5):601-18. PubMed ID: 15926867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.